Effect of Calorie Restriction on Mood, Quality of Life, Sleep, and Sexual Function in Healthy Nonobese Adults: The CALERIE 2 Randomized Clinical Trial - PubMed (original) (raw)
Randomized Controlled Trial
. 2016 Jun 1;176(6):743-52.
doi: 10.1001/jamainternmed.2016.1189.
Manju Bhapkar 2, Anastassios G Pittas 3, Carl F Pieper 2, Sai Krupa Das 4, Donald A Williamson 1, Tammy Scott 4, Leanne M Redman 1, Richard Stein 5, Cheryl H Gilhooly 4, Tiffany Stewart 1, Lisa Robinson 4, Susan B Roberts 4; Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) Phase 2 Study Group
Affiliations
- PMID: 27136347
- PMCID: PMC4905696
- DOI: 10.1001/jamainternmed.2016.1189
Randomized Controlled Trial
Effect of Calorie Restriction on Mood, Quality of Life, Sleep, and Sexual Function in Healthy Nonobese Adults: The CALERIE 2 Randomized Clinical Trial
Corby K Martin et al. JAMA Intern Med. 2016.
Abstract
Importance: Calorie restriction (CR) increases longevity in many species and reduces risk factors for chronic diseases. In humans, CR may improve health span, yet concerns remain about potential negative effects of CR.
Objective: To test the effect of CR on mood, quality of life (QOL), sleep, and sexual function in healthy nonobese adults.
Design, setting, and participants: A multisite randomized clinical trial (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy Phase 2 [CALERIE 2]) was conducted at 3 academic research institutions. Adult men and women (N = 220) with body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) of 22.0 to 28.0 were randomized to 2 years of 25% CR or an ad libitum (AL) control group in a 2:1 ratio favoring CR. Data were collected at baseline, 12 months, and 24 months and examined using intent-to-treat analysis. The study was conducted from January 22, 2007, to March 6, 2012. Data analysis was performed from July 18, 2012, to October 27, 2015.
Interventions: Two years of 25% CR or AL.
Main outcomes and measures: Self-report questionnaires were administered to measure mood (Beck Depression Inventory-II [BDI-II], score range 0-63, higher scores indicating worse mood, and Profile of Mood States [POMS], with a total mood disturbance score range of -32 to 200 and higher scores indicating higher levels of the constructs measured), QOL (Rand 36-Item Short Form, score range 0-100, higher scores reflecting better QOL, and Perceived Stress Scale, score range 0-40, higher scores indicating higher levels of stress), sleep (Pittsburgh Sleep Quality Index [PSQI], total score range 0-21, higher scores reflecting worse sleep quality), and sexual function (Derogatis Interview for Sexual Function-Self-report, total score range 24-188, higher scores indicating better sexual functioning).
Results: In all, 218 participants (152 women [69.7%]; mean [SD] age, 37.9 (7.2) years; mean [SD] BMI, 25.1 [1.6]) were included in the analyses. The CR and AL groups lost a mean (SE) of 7.6 (0.3) kg and 0.4 (0.5) kg, respectively, at month 24 (P < .001). Compared with the AL group, the CR group had significantly improved mood (BDI-II: between-group difference [BGD], -0.76; 95% CI, -1.41 to -0.11; effect size [ES], -0.35), reduced tension (POMS: BGD, -0.79; 95% CI, -1.38 to -0.19; ES, -0.39), and improved general health (BGD, 6.45; 95% CI, 3.93 to 8.98; ES, 0.75) and sexual drive and relationship (BGD, 1.06; 95% CI, 0.11 to 2.01; ES, 0.35) at month 24 as well as improved sleep duration at month 12 (BGD, -0.26; 95% CI, -0.49 to -0.02; ES, -0.32) (all P < .05). Greater percent weight loss in the CR group at month 24 was associated with increased vigor (Spearman correlation coefficient, ρ = -0.30) and less mood disturbance (ρ = 0.27) measured with the POMS, improved general health (ρ = -0.27) measured with the SF-36, and better sleep quality per the PSQI total score (ρ = 0.28) (all P < .01).
Conclusions and relevance: In nonobese adults, CR had some positive effects and no negative effects on health-related QOL.
Trial registration: clinicaltrials.gov Identifier: NCT00427193.
Conflict of interest statement
Conflict of Interest Disclosures: None reported.
Figures
Figure 1. CONSORT Diagram
More than 10 000 people expressed interest in the study, and 238 people completed the screening process and were eligible. All 218 participants who started the intervention (calorie restriction [CR], 143; ad libitum [AL], 75) were included in the main study analysis. Adapted from Ravussin et al.
Figure 2. Illustration of Interaction Effects
Estimated changes in the end points for the ad libitum (AL) group are represented by solid circles. Estimated change in the end points for the calorie restriction (CR) group are represented by open circles. Illustrations of a body mass index × treatment × time interaction (A and B) and a sex × treatment interaction (C and D) for the Profile of Mood States (POMS) depression subscale are provided. In addition, a sex × treatment interaction on the sexual arousal subscale of the Derogatis Interview for Sexual Function–Self-report is illustrated (E and F). Error bars indicate SE. a Significant differences between the AL and CR groups are denoted at the specified time point, with P = .005 for the difference between the AL and CR overweight participants at month 24 on the POMS depression scale; P = .03 and P = .02 for the difference between the AL and CR men on the POMS depression scale at months 6 and 12, respectively; and P = .04 for the difference between the AL and CR men at month 12on the sexual arousal scale.
Comment in
- Obesity Management and Prevention: More Questions Than Answers.
Moin T. Moin T. JAMA Intern Med. 2016 Jun 1;176(6):753-4. doi: 10.1001/jamainternmed.2016.1211. JAMA Intern Med. 2016. PMID: 27135966 No abstract available. - Healthy Behaviors Potentially Due to Calorie Restriction.
Tufan F, Soyluk O, Karan MA. Tufan F, et al. JAMA Intern Med. 2016 Nov 1;176(11):1724. doi: 10.1001/jamainternmed.2016.6190. JAMA Intern Med. 2016. PMID: 27820642 No abstract available. - Healthy Behaviors Potentially Due to Calorie Restriction-Reply.
Martin CK, Bhapkar M, Roberts SB; CALERIE Study Group. Martin CK, et al. JAMA Intern Med. 2016 Nov 1;176(11):1724. doi: 10.1001/jamainternmed.2016.6201. JAMA Intern Med. 2016. PMID: 27820645 No abstract available. - Caloric restriction improves health-related quality of life in healthy normal weight and overweight individuals.
Butsch WS, Stanford FC. Butsch WS, et al. Evid Based Med. 2017 Mar;22(1):33. doi: 10.1136/ebmed-2016-110526. Epub 2016 Nov 23. Evid Based Med. 2017. PMID: 27881466 Free PMC article. No abstract available. - Re: Effect of Calorie Restriction on Mood, Quality of Life, Sleep, and Sexual Function in Healthy Nonobese Adults: The CALERIE 2 Randomized Clinical Trial.
Seftel AD. Seftel AD. J Urol. 2017 May;197(5):1332-1334. doi: 10.1016/j.juro.2017.02.059. Epub 2017 Feb 21. J Urol. 2017. PMID: 29539939 No abstract available.
Similar articles
- Body-composition changes in the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE)-2 study: a 2-y randomized controlled trial of calorie restriction in nonobese humans.
Das SK, Roberts SB, Bhapkar MV, Villareal DT, Fontana L, Martin CK, Racette SB, Fuss PJ, Kraus WE, Wong WW, Saltzman E, Pieper CF, Fielding RA, Schwartz AV, Ravussin E, Redman LM; CALERIE-2 Study Group. Das SK, et al. Am J Clin Nutr. 2017 Apr;105(4):913-927. doi: 10.3945/ajcn.116.137232. Epub 2017 Feb 22. Am J Clin Nutr. 2017. PMID: 28228420 Free PMC article. Clinical Trial. - Effect of Time-Restricted Eating versus Daily Calorie Restriction on Mood and Quality of Life in Adults with Obesity.
Lin S, Cienfuegos S, Ezpeleta M, Pavlou V, Chakos K, McStay M, Runchey MC, Alexandria SJ, Varady KA. Lin S, et al. Nutrients. 2023 Oct 10;15(20):4313. doi: 10.3390/nu15204313. Nutrients. 2023. PMID: 37892388 Free PMC article. Clinical Trial. - Efficacy of fasting calorie restriction on quality of life among aging men.
Teng NI, Shahar S, Manaf ZA, Das SK, Taha CS, Ngah WZ. Teng NI, et al. Physiol Behav. 2011 Oct 24;104(5):1059-64. doi: 10.1016/j.physbeh.2011.07.007. Epub 2011 Jul 18. Physiol Behav. 2011. PMID: 21781980 Clinical Trial. - Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].
LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. LeBlanc EL, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review. - Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].
Patnode CD, Evans CV, Senger CA, Redmond N, Lin JS. Patnode CD, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. PMID: 29364620 Free Books & Documents. Review.
Cited by
- Intermittent Fasting: Socio-Economic Profile of Spanish Citizens Who Practice It and the Influence of This Dietary Pattern on the Health and Lifestyle Habits of the Population.
Sandri E, Borghesi D, Cantín Larumbe E, Cerdá Olmedo G, Vega-Bello MJ, Bernalte Martí V. Sandri E, et al. Nutrients. 2024 Jun 26;16(13):2028. doi: 10.3390/nu16132028. Nutrients. 2024. PMID: 38999776 Free PMC article. - Epigenetic regulation of aging: implications for interventions of aging and diseases.
Wang K, Liu H, Hu Q, Wang L, Liu J, Zheng Z, Zhang W, Ren J, Zhu F, Liu GH. Wang K, et al. Signal Transduct Target Ther. 2022 Nov 7;7(1):374. doi: 10.1038/s41392-022-01211-8. Signal Transduct Target Ther. 2022. PMID: 36336680 Free PMC article. Review. - The effect of prebiotic supplementation on serum levels of tryptophan and kynurenine in obese women with major depressive disorder: a double-blinded placebo-controlled randomized clinical trial.
Khademi F, Tutunchi H, Vaghef-Mehrabani E, Ebrahimi-Mameghani M. Khademi F, et al. BMC Res Notes. 2024 Oct 20;17(1):316. doi: 10.1186/s13104-024-06963-w. BMC Res Notes. 2024. PMID: 39428497 Free PMC article. Clinical Trial. - Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism.
Shintani H, Shintani T, Ashida H, Sato M. Shintani H, et al. Nutrients. 2018 Nov 22;10(12):1821. doi: 10.3390/nu10121821. Nutrients. 2018. PMID: 30469486 Free PMC article. Review. - Adipose tissue aging: mechanisms and therapeutic implications.
Ou MY, Zhang H, Tan PC, Zhou SB, Li QF. Ou MY, et al. Cell Death Dis. 2022 Apr 4;13(4):300. doi: 10.1038/s41419-022-04752-6. Cell Death Dis. 2022. PMID: 35379822 Free PMC article. Review.
References
- Speakman JR, Mitchell SE. Caloric restriction. Mol Aspects Med. 2011;32(3):159–221. - PubMed
- Bodkin NL, Alexander TM, Ortmeyer HK, Johnson E, Hansen BC. Mortality and morbidity in laboratory-maintained rhesus monkeys and effects of long-term dietary restriction. J Gerontol A Biol Sci Med Sci. 2003;58(3):212–219. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 AG020487/AG/NIA NIH HHS/United States
- U01 AG020478/AG/NIA NIH HHS/United States
- U01 AG020480/AG/NIA NIH HHS/United States
- U01 AG022132/AG/NIA NIH HHS/United States
- P30 DK072476/DK/NIDDK NIH HHS/United States
- U54 GM104940/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources